Chaow Charoenkijkajorn
Sourced from institutional research profiles (UAMS TRI or ARA).
Researcher
Also affiliated: Texas Medical Center (2022); The University of Texas MD Anderson Cancer Center (2022–2023); Cornell University (2022–2023); University of Arkansas Medical Center (2026); University of Iowa Hospitals and Clinics (2022–2023); Methodist Hospital (2022–2025); Vision Eye Institute (2023); Vanderbilt Health (2022); Weill Cornell Medicine (2022–2023); The University of Texas Medical Branch at Galveston (2022–2023); Smith-Kettlewell Eye Research Institute (2023–2024); Bryan College (2022); Stanford University (2023–2026)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Chaow Charoenkijkajorn's research focuses on ophthalmology, with a particular emphasis on optic nerve diseases and vascular conditions affecting the eye. Recent publications investigate posterior ischemic optic neuropathy in the context of COVID-19 and prior optic neuropathies, as well as uveomeningeal syndrome presenting with optic disc edema and white dot syndrome. Other work includes the study of rare orbital cavernous hemangiomas, audible blink in carotid-cavernous fistula, and large-vessel vasculitis in ophthalmology, such as giant cell arteritis and Takayasu arteritis. Charoenkijkajorn has also explored the risk of giant cell arteritis in patients with undifferentiated noninfectious uveitis and evaluated antifibrotic agents for glaucoma filtration surgery. Scholarship metrics include an h-index of 3, with 47 total publications and 47 total citations.
Metrics
- h-index: 3
- Publications: 47
- Citations: 47
Selected Publications
-
Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports (2026)
-
Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis (2025)
Collaboration Network
Top Collaborators
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
Similar Researchers
Based on overlapping research topics